Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives.
about
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and PerspectivesChemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins.Genetics of pancreatic neuroendocrine tumors: implications for the clinic.Everolimus induces Met inactivation by disrupting the FKBP12/Met complexBiphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment.Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms.
P2860
Q28071388-0F0325F3-4824-42C3-81B5-238A32948C03Q28553712-F5F1F63A-1294-49B7-80AC-FF4B5FAC3564Q36960581-37C3A866-D618-4A42-BDF4-87CA116D9B40Q37457794-882B8C4D-D236-4D79-AC63-3F3D4DB60B21Q38741294-43A9EFAA-F066-4C2C-8812-083DF377A59CQ39156308-44669963-B9EA-44E5-A4AD-37450C7140FEQ47847243-7157DA44-4B11-43C7-A619-CAD128ADAD98
P2860
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Suppression of mTOR pathway in ...... e tumors and new perspectives.
@en
type
label
Suppression of mTOR pathway in ...... e tumors and new perspectives.
@en
prefLabel
Suppression of mTOR pathway in ...... e tumors and new perspectives.
@en
P2860
P50
P356
P1433
P1476
Suppression of mTOR pathway in ...... ne tumors and new perspectives
@en
P2093
Chiara Ciccarese
Silvia Ortolani
P2860
P304
P356
10.2217/FON.15.81
P407
P577
2015-01-01T00:00:00Z